141 related articles for article (PubMed ID: 35753771)
1. Safety of linezolid, rifampicin, and clindamycin combination therapy in patients with prosthetic joint infection.
Kobayashi S; Tagawa S; Ogura T; Kitaoka A; Yasu T
Drug Discov Ther; 2022 Jul; 16(3):142-144. PubMed ID: 35753771
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?
Legout L; Valette M; Dezeque H; Nguyen S; Lemaire X; Loïez C; Caillaux M; Beltrand E; Dubreuil L; Yazdanpanah Y; Migaud H; Senneville E
J Antimicrob Chemother; 2010 Oct; 65(10):2224-30. PubMed ID: 20675299
[TBL] [Abstract][Full Text] [Related]
3. Linezolid-induced rare triad of hypoglycaemia, bone marrow suppression and hyponatraemia in elderly.
Singhania SVK; Shenoy S; Kapoor D
J Clin Pharm Ther; 2020 Apr; 45(2):376-378. PubMed ID: 31657870
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia.
Hanai Y; Matsuo K; Ogawa M; Higashi A; Kimura I; Hirayama S; Kosugi T; Nishizawa K; Yoshio T
J Infect Chemother; 2016 Aug; 22(8):536-42. PubMed ID: 27321773
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: A case report.
Kobayashi S; Kase M; Matsubara M; Kitaoka A; Yasu T
Int J Clin Pharmacol Ther; 2021 Sep; 59(9):627-629. PubMed ID: 34190685
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis of myelosuppression in pediatric patients treated with linezolid for Gram-positive bacterial infections.
Kato H; Hagihara M; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2021 Aug; 27(8):1143-1150. PubMed ID: 33727025
[TBL] [Abstract][Full Text] [Related]
7. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment.
Plachouras D; Giannitsioti E; Athanassia S; Kontopidou F; Papadopoulos A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2006 Nov; 43(9):e89-91. PubMed ID: 17029128
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.
Albrecht J; Baine PA; Ladizinski B; Jemec GB; Bigby M
Br J Dermatol; 2019 Apr; 180(4):749-755. PubMed ID: 30281779
[TBL] [Abstract][Full Text] [Related]
9. Hematologic effects of linezolid in young children.
Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective Analysis of Risk Factors for Linezolid-Associated Hyponatremia in Japanese Patients.
Tanaka R; Suzuki Y; Takumi Y; Iwao M; Sato Y; Hashinaga K; Hiramatsu K; Kadota JI; Itoh H
Biol Pharm Bull; 2016; 39(12):1968-1973. PubMed ID: 27904038
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
Hamad T; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
APMIS; 2015 Dec; 123(12):1055-60. PubMed ID: 26547372
[TBL] [Abstract][Full Text] [Related]
12. [Myelosupression induced by linezolid: a pediatric case].
Ballesteros García MDM; Orós Milián ME; Díaz Velázquez E; Alarcón Alacio MT; Galán Del Río P
Arch Argent Pediatr; 2017 Dec; 115(6):e420-e423. PubMed ID: 29087126
[TBL] [Abstract][Full Text] [Related]
13. [Verification of Relationship between Administration of Linezolid and Vomiting].
Tsutsumi T; Imai S; Yamada K; Yamada T; Kasashi K; Kobayashi M; Iseki K
Yakugaku Zasshi; 2019; 139(7):1055-1061. PubMed ID: 31257252
[TBL] [Abstract][Full Text] [Related]
14. Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective.
von Dach E; Morel CM; Murthy A; Pagani L; Macedo-Vinas M; Olearo F; Harbarth S
Clin Microbiol Infect; 2017 Sep; 23(9):659-666. PubMed ID: 28232163
[TBL] [Abstract][Full Text] [Related]
15. Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection.
Harbarth S; von Dach E; Pagani L; Macedo-Vinas M; Huttner B; Olearo F; Emonet S; Uçkay I
J Antimicrob Chemother; 2015 Jan; 70(1):264-72. PubMed ID: 25209610
[TBL] [Abstract][Full Text] [Related]
16. A retrospective test for a possible relationship between linezolid-induced thrombocytopenia and hyponatraemia.
Tanaka R; Suzuki Y; Morinaga Y; Iwao M; Takumi Y; Hashinaga K; Tatsuta R; Hiramatsu K; Kadota JI; Itoh H
J Clin Pharm Ther; 2021 Apr; 46(2):343-351. PubMed ID: 33016566
[TBL] [Abstract][Full Text] [Related]
17. A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention.
Morata L; Senneville E; Bernard L; Nguyen S; Buzelé R; Druon J; Tornero E; Mensa J; Soriano A
Infect Dis Ther; 2014 Dec; 3(2):235-43. PubMed ID: 25139552
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.
Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235
[No Abstract] [Full Text] [Related]
19. Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.
Ashizawa N; Tsuji Y; Kawago K; Higashi Y; Tashiro M; Nogami M; Gejo R; Narukawa M; Kimura T; Yamamoto Y
J Infect Chemother; 2016 May; 22(5):331-4. PubMed ID: 26732509
[TBL] [Abstract][Full Text] [Related]
20. Hematologic effects of linezolid: summary of clinical experience.
Gerson SL; Kaplan SL; Bruss JB; Le V; Arellano FM; Hafkin B; Kuter DJ
Antimicrob Agents Chemother; 2002 Aug; 46(8):2723-6. PubMed ID: 12121967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
